JP2019513138A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019513138A5 JP2019513138A5 JP2018550558A JP2018550558A JP2019513138A5 JP 2019513138 A5 JP2019513138 A5 JP 2019513138A5 JP 2018550558 A JP2018550558 A JP 2018550558A JP 2018550558 A JP2018550558 A JP 2018550558A JP 2019513138 A5 JP2019513138 A5 JP 2019513138A5
- Authority
- JP
- Japan
- Prior art keywords
- concentration
- potassium
- phosphorus
- mannitol
- serum albumin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662316262P | 2016-03-31 | 2016-03-31 | |
| US62/316,262 | 2016-03-31 | ||
| PCT/US2017/024365 WO2017172643A1 (en) | 2016-03-31 | 2017-03-27 | Compositions and methods for stabilizing alphaviruses with improved formulations |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019513138A JP2019513138A (ja) | 2019-05-23 |
| JP2019513138A5 true JP2019513138A5 (enExample) | 2020-07-09 |
Family
ID=58537071
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018550558A Withdrawn JP2019513138A (ja) | 2016-03-31 | 2017-03-27 | 改良された製剤によりアルファウイルスを安定化するための組成物及び方法 |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US10632184B2 (enExample) |
| EP (1) | EP3436063A1 (enExample) |
| JP (1) | JP2019513138A (enExample) |
| KR (1) | KR20180135912A (enExample) |
| CN (1) | CN109069614A (enExample) |
| AU (1) | AU2017241590A1 (enExample) |
| BR (1) | BR112018069035A2 (enExample) |
| CA (1) | CA3019529A1 (enExample) |
| CO (1) | CO2018010357A2 (enExample) |
| CR (1) | CR20180456A (enExample) |
| DO (1) | DOP2018000211A (enExample) |
| EC (1) | ECSP18081486A (enExample) |
| MX (1) | MX2018011837A (enExample) |
| NI (1) | NI201800096A (enExample) |
| PE (1) | PE20190149A1 (enExample) |
| PH (1) | PH12018502119A1 (enExample) |
| SG (1) | SG11201808458QA (enExample) |
| SV (1) | SV2018005747A (enExample) |
| WO (1) | WO2017172643A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10538785B2 (en) | 2013-12-23 | 2020-01-21 | Renaud Vaillant | Lyophilized lentiviral vector particles, compositions and methods |
| IL290450B2 (en) * | 2019-08-09 | 2025-07-01 | Valneva Se | Single shot chikungunya virus vaccine |
| MX2022001430A (es) * | 2019-08-09 | 2022-02-22 | Valneva Se | Formulaciones de vacuna contra chikungu?a. |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5545555A (en) * | 1994-07-25 | 1996-08-13 | Microtest, Inc. | Microbial transport media |
| US8865184B2 (en) | 2006-09-01 | 2014-10-21 | Bharat Biotech International Limited | Vaccine for chikungunya virus infection |
| US9314519B2 (en) * | 2012-08-21 | 2016-04-19 | Intervet Inc. | Liquid stable virus vaccines |
| TWI690322B (zh) * | 2012-10-02 | 2020-04-11 | 法商傳斯堅公司 | 含病毒的調配物及其使用 |
| EP2968515B1 (en) * | 2013-03-14 | 2019-05-08 | Takeda Vaccines, Inc. | Compositions and methods for live, attenuated alphavirus formulations |
| CN104984357B (zh) * | 2015-06-02 | 2018-01-30 | 长春百克生物科技股份公司 | 不含明胶的疫苗保护剂组合物及流感减毒活疫苗 |
-
2017
- 2017-03-27 SG SG11201808458QA patent/SG11201808458QA/en unknown
- 2017-03-27 EP EP17717027.1A patent/EP3436063A1/en not_active Withdrawn
- 2017-03-27 CA CA3019529A patent/CA3019529A1/en not_active Abandoned
- 2017-03-27 US US16/088,816 patent/US10632184B2/en not_active Expired - Fee Related
- 2017-03-27 MX MX2018011837A patent/MX2018011837A/es unknown
- 2017-03-27 JP JP2018550558A patent/JP2019513138A/ja not_active Withdrawn
- 2017-03-27 CR CR20180456A patent/CR20180456A/es unknown
- 2017-03-27 AU AU2017241590A patent/AU2017241590A1/en not_active Abandoned
- 2017-03-27 CN CN201780026126.8A patent/CN109069614A/zh active Pending
- 2017-03-27 KR KR1020187031479A patent/KR20180135912A/ko not_active Ceased
- 2017-03-27 BR BR112018069035A patent/BR112018069035A2/pt not_active IP Right Cessation
- 2017-03-27 PE PE2018001924A patent/PE20190149A1/es unknown
- 2017-03-27 WO PCT/US2017/024365 patent/WO2017172643A1/en not_active Ceased
-
2018
- 2018-09-27 CO CONC2018/0010357A patent/CO2018010357A2/es unknown
- 2018-09-27 NI NI201800096A patent/NI201800096A/es unknown
- 2018-09-28 DO DO2018000211A patent/DOP2018000211A/es unknown
- 2018-09-28 SV SV2018005747A patent/SV2018005747A/es unknown
- 2018-10-01 PH PH12018502119A patent/PH12018502119A1/en unknown
- 2018-10-30 EC ECSENADI201881486A patent/ECSP18081486A/es unknown
-
2020
- 2020-04-08 US US16/843,439 patent/US20200306361A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010529999A5 (enExample) | ||
| JP2017535616A5 (enExample) | ||
| JP2015527402A5 (enExample) | ||
| EA201791111A1 (ru) | Пероральная регидратационанная композиция и способы | |
| JP2011088913A5 (enExample) | ||
| NZ629261A (en) | Pharmaceutical formulations of tnf-alpha antibodies | |
| CY1124076T1 (el) | Ημιθειικο αλας του 5,10-μεθυλενο-(6r)-τετραϋδροφυλλικου οξεος | |
| BR112014009073A2 (pt) | formulações de etanercepte estabilizadas com cloreto de sódio | |
| HRP20200434T1 (hr) | Stabilne vodene formulacije adalimumaba | |
| JP2019513138A5 (enExample) | ||
| JP2013193968A5 (enExample) | ||
| BR112015022210A8 (pt) | formulações de anticorpo | |
| JP2012515221A5 (enExample) | ||
| EA201490610A1 (ru) | Соединения и способы усиления врожденных иммунных ответов | |
| JP2013508315A5 (enExample) | ||
| JP2015535237A5 (enExample) | ||
| JP2021505620A5 (enExample) | ||
| JP2015510882A5 (enExample) | ||
| MX2021012968A (es) | Formulaciones de anticuerpo de baja viscosidad, estables y usos de las mismas. | |
| HRP20200196T1 (hr) | Fiziološki balansirane injektabilne formulacije fosnetupitanta | |
| JP2020517665A5 (enExample) | ||
| JP2017019841A5 (enExample) | ||
| JP2019532635A5 (enExample) | ||
| JP2017007966A5 (enExample) | ||
| AR113066A1 (es) | Substituto de sal baja en sodio con cloruro de potasio |